San Martin Javier
SEC insider (Form 3/4/5 filer). CIK 0001794629. CHIEF MEDICAL OFFICER at LeonaBio, Inc. (LONA). 14 reported Form 4/5 transactions since Sep 2024; latest on Apr 9, 2026. Located in BOTHELL, WA.
Companies San Martin Javier has filed insider reports for
- LeonaBio, Inc. (LONA): Officer, CHIEF MEDICAL OFFICER
San Martin Javier
CIK: 0001794629
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
LeonaBio, Inc.
Discretionary Trading P&L
Holdings
Transaction History (14 total)
- Apr 9, 2026LONA
LeonaBio, Inc.
AwardDirectStock Option (Right to Buy)
350K shares- - Mar 4, 2026LONA
LeonaBio, Inc.
SaleDirect1.7K shares at avg. $5.37$9K - Mar 3, 2026LONA
LeonaBio, Inc.
ExerciseDirect7.4K shares- - Jan 2, 2026ATHA
Athira Pharma, Inc.
SaleDirect1.6K shares at avg. $6.88$11K - Dec 31, 2025ATHA
Athira Pharma, Inc.
ExerciseDirect4.7K shares- - Dec 24, 2025ATHA
Athira Pharma, Inc.
AwardDirectStock Option (Right to Buy)
44.5K shares- - Jul 1, 2025ATHA
Athira Pharma, Inc.
SaleDirect10.8K shares at avg. $0.29$3K - Jun 30, 2025ATHA
Athira Pharma, Inc.
ExerciseDirect46.7K shares- - Mar 3, 2025ATHA
Athira Pharma, Inc.
AwardDirectStock Option (Right to Buy)
111.3K shares- - Mar 3, 2025ATHA
Athira Pharma, Inc.
AwardDirectRestricted Stock Units
74.2K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Apr 9, 2026 | LONA LeonaBio, Inc. | Award Stock Option (Right to Buy) | 350,000 | - | - | Direct |
| Mar 4, 2026 | LONA LeonaBio, Inc. | Sale | 1,720 | $5.37 | $9,236 | Direct |
| Mar 3, 2026 | LONA LeonaBio, Inc. | Exercise | 7,418 | - | $0 | Direct |
| Jan 2, 2026 |  ATHA Athira Pharma, Inc. | Sale | 1,644 | $6.88 | $11,311 | Direct |
| Dec 31, 2025 | ATHA Athira Pharma, Inc. | Exercise | 4,667 | - | $0 | Direct |
| Dec 24, 2025 | ATHA Athira Pharma, Inc. | Award Stock Option (Right to Buy) | 44,508 | - | - | Direct |
| Jul 1, 2025 | ATHA Athira Pharma, Inc. | Sale | 10,842 | $0.29 | $3,182 | Direct |
| Jun 30, 2025 | ATHA Athira Pharma, Inc. | Exercise | 46,666 | - | - | Direct |
| Mar 3, 2025 | ATHA Athira Pharma, Inc. | Award Stock Option (Right to Buy) | 111,270 | - | - | Direct |
| Mar 3, 2025 | ATHA Athira Pharma, Inc. | Award Restricted Stock Units | 74,180 | - | - | Direct |
1-10 of 14 transactions